An outside the united states customer observed an elevated immulite 2000 xpi human chorionic gonadotropin (hcg) result for a patient sample compared to repeat testing with the same sample.Siemens healthcare diagnostics is investigating this event.The limitations section of the instructions for use states the following: "for diagnostic purposes, the results obtained from this assay should always be used in combination with the clinical examination, patient medical history, and other findings.".
|
Mdr 1219913-2022-00044 was filed on january 26, 2022.Additional information - january 31, 2022.An outside the united states customer reports immulite 2000/xpi hcg non-reproducible patient results that are higher than expected.The customer informed siemens that sample tubes are centrifuged for at least 30 minutes.Siemens evaluated precision data provided by the customer and determed that acceptable precision was observed.This customer has not reported any concerns with immulite 2000/xpi hcg adjustment and/or quality control (qc) performance.The customer is repeating samples that result 6-80 iu/ml.Siemens is continuing to investigate.
|
Initial mdr 1219913-2022-00044 was filed on january 26, 2022.Mdr 1219913-2022-00044 supplemental-1 was filed on february 24, 2022.Additional information - february 22, 2022 siemens healthcare diagnostics further investigated the issue and confirmed the potential for falsely elevated human chorionic gonadotropin (hcg) results due to sample carryover.This can be observed when a sample is assayed for hcg immediately after an undiluted sample with a hcg value of >5000 miu/ml.This issue impacts serum and urine patient samples, as well as quality control samples and adjustors.The effect of carryover varies based on the concentration of the high hcg sample.Starting 2022-02-22 an urgent medical device correction (umdc, letter imc22-04.A.Us) was sent to us customers, and an urgent field safety notice (ufsn, letter imc22-04.A.Ous) was sent to outside the us (ous).The umdc and ufsn explain the potential for carryover from high hcg samples into the next sample assayed for hcg on the immulite 2000/immulite 2000 xpi, and provides instructions to the customers.In section h6, type of investigation, investigation finding, and investigation conclusion codes were updated based on additional information.Section h7 was updated to reflect a recall and section h9 was updated to include the correction/ removal reporting number.
|